JS

Jorawer Singh Sisodiya

Director Director DIN 07730759
DIN 07730759 First appointment Feb 2017 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2017
Shareholding value •••• Premium profile

About Jorawer Singh Sisodiya

Data last updated:

Jorawer Singh Sisodiya was a Director at Handsome Friend Private Limited (2019–2022) and Director at Traxxim Biomedicines Private Limited (2017–2022). The companies operate in Business Services and Pharma.

DIN 07730759
Primary Designation Director
Industry Business Services
First Appointment 09 Feb 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Handsome Friend Private Limited U74999GJ2019PTC106804
Director25 Feb 20192019Active
Traxxim Biomedicines Private Limited U24232GJ2007PTC051746
Director09 Feb 20172007₹47.81 Cr (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Handsome Friend Private Limited
Traxxim Biomedicines Private Limited
Premium access

Shareholding and investment profile for Jorawer Singh Sisodiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jorawer Singh Sisodiya

Jorawer Singh Sisodiya was first appointed on 09 Feb 2017 as Director at Traxxim Biomedicines Private Limited. The most recent appointment on record is 25 Feb 2019 at Handsome Friend Private Limited.

Jorawer Singh Sisodiya held 2 earlier board appointments: Handsome Friend Private Limited (Director, 25 Feb 2019 to 20 Jan 2022); Traxxim Biomedicines Private Limited (Director, 09 Feb 2017 to 20 Oct 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available